Keeping a new whooping cough outbreak at bay

With a whooping cough outbreak on the way, pharmacists can help to protect those most at risk through promoting testing and vaccination.

Aspiration precautions for diabetes and weight-management therapies

Following several incident reports, the Therapeutic Goods Administration issued new precautions linked to these popular therapies.

Valvular heart disease: how pharmacists can help

More than 250,000 Australians have faulty heart valves and are at risk of serious complications, including heart failure, stroke and death – yet don’t know it. Australian Pharmacist spoke to an expert about the symptoms pharmacists should be aware of.

Dealing with aggressive customers? You’re not alone

As confirmed cases of COVID-19 in Australia tick over 4,700, many pharmacists face long working hours and the rising challenge of unacceptable customer behaviour.

Should ibuprofen be used for COVID-19 symptoms?

There is currently no peer-reviewed, published scientific evidence to support a direct link between use of ibuprofen and more severe infection with COVID-19.

Ozempic now indicated to prevent CKD progression

Ozempic is the first medicine in Australia approved to slow kidney disease progression in patients with both type 2 diabetes and CKD.